Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latest From Itochu Corp.

Venture Funding Deals: Takeda's Phathom Raises $140m In Crossover Round For GERD Program

AgomAb, CinCor and Confo Therapeutics secure Series A financing, while AlloVir closes a $121m Series B and more venture financing in April and May.

Deals Financing

Finance Watch: Former Juno Execs Launch Sana With Allogeneic Cell Therapy Platform

Private Company Edition: Former Juno execs launch allogeneic cell therapy venture Sana, Atlas raises a $250m fund, and the Rakuten Aspyrian, Apollomics and Antengene VC deals exceed the $100m mark.

Financing StartUps and SMEs

Asia On The Move: Lundbeck China Research Head Leaves For GSK

A plethora of personnel changes is taking place in the pharmaceutical industry around Asia as a new year arrives.

BioPharmaceutical China

Elekta’s Project Atlantic: A New Blue Ocean For Radiation Therapy

The firm's so-called Project Atlantic radiation therapy system combines high-field real-time MR imaging with state-of-the-art linear technology that Elekta says will take the standard of care to the next level. It is aiming for European and U.S. approvals in 2017.

Medical Device
See All

Company Information

  • Industry
  • Diversified